Elevance Health (ELV) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Elevance Health, as the data feed reports them.

Analysts' mean target, 21 analysts
$482.38
11.2% above the price

The 21 analysts reported by the data feed have a mean price target for Elevance Health of $482.38, 11.2% above the $433.93 price (range $406.00–$523.00). 2.36% of the float was sold short as of Oct 30, 2026. Institutions hold 94.1% of the shares and insiders 0.2%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$482.38+11.2% vs price
Analysts
21
Short interest
2.36%of float, Oct 30, 2026
Short ratio
3.4 days
Institutions
94.1%
Insiders
0.21%
Beta
0.63
Next earnings
Jan 28, 2027estimated

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

21 analysts covering Elevance Health, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $433.93.

Analysts' price targets for Elevance Health
Mean price target$482.3811.2% above the price (+11.2%)
Median price target$492.0013.4% above the price (+13.4%)
Highest target$523.0020.5% above the price (+20.5%)
Lowest target$406.006.4% below the price (−6.4%)
Analysts with a target21

Ratings this month · 22 analysts

Strong buy 3(14%)Buy 12(55%)Hold 7(32%)
Analysts' ratings of Elevance Health this month, by rating
RatingAnalystsShare
Strong buy314%
Buy1255%
Hold732%
Sell00%
Strong sell00%

The feed averages these to 1.77 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “buy”.

Who owns Elevance Health

Ownership of Elevance Health
Held by institutions94.1%2,203 institutions; percent of shares outstanding
Held by institutions, of the float94.3%
Held by insiders0.21%percent of shares outstanding
Shares outstanding216.06M
Float215.57Mshares available to trade
Insiders' net purchases, six months+5.83K4 purchases (7.88K shares), 3 sales (2.05K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Elevance Health
Shares short4.54Mas of Oct 30, 2026
Percent of float2.36%shares short ÷ float
Percent of shares outstanding2.10%shares short ÷ shares outstanding
Short ratio (days to cover)3.4shares short ÷ average daily volume

Elevance Health short interest from FINRA, with its history

Trading figures

Trading figures for Elevance Health
Beta0.63movement against the market; 1 moves with it
52-week high$450.69
52-week low$274.84
Average volume, 3 months1.24Mshares a day
Average volume, 10 days1.32Mshares a day

Dates to know

Upcoming and recent dates for Elevance Health
Next earnings reportJan 28, 2027the feed's estimate, not confirmed
Ex-dividend dateDec 4, 2026as the feed lists it
Dividend payment dateDec 18, 2026

Questions and answers

What is the analysts' price target for Elevance Health (ELV)?

As reported by the data feed, the mean price target of the 21 analysts covering Elevance Health is $482.38, 11.2% above the latest price of $433.93. The highest target is $523.00 and the lowest $406.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Elevance Health stock?

Of the 22 ratings the data feed reports for the current month, 3 are strong buy, 12 buy, 7 hold, 0 sell and 0 strong sell.

How many Elevance Health shares are sold short?

As reported by the data feed, 4.54M shares were sold short, 2.36% of the float as of Oct 30, 2026. At the average daily volume that is 3.4 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Elevance Health stock?

As reported by the data feed, institutions hold 94.1% of the shares (2,203 institutions) and insiders 0.2%. There are 216.06M shares outstanding, of which 215.57M are in the float.

When is Elevance Health's next earnings report?

The data feed lists Jan 28, 2027, marked as its estimate rather than a date the company has confirmed. The latest ex-dividend date it lists is Dec 4, 2026.

How much does Elevance Health stock move with the market?

Its beta, as reported by the data feed, is 0.63: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $274.84 and $450.69.

Cite this page

Funkfolio, “Elevance Health (ELV) statistics: analyst targets and short interest”, data as of 17 November 2026. https://funkfolio.com/stock/ELV/statistics

Underlying data: Yahoo Finance.